Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 2,182 | 4,784 | 1,192 | 1,631 | 718 |
| Gross Profit | 2,182 | 4,784 | 1,192 | 1,631 | 718 |
| Operating Expenses | 11,043 | 9,403 | 7,546 | 7,520 | 8,068 |
| Operating Income | -8,861 | -4,619 | -6,354 | -5,889 | -7,350 |
| Interest Expense | 214 | 209 | 190 | 58 | 64 |
| Other Income | 361 | 167 | 158 | 113 | 102 |
| Pre-tax Income | -8,714 | -4,661 | -6,386 | -5,834 | -7,312 |
| Net Income Continuous | -8,714 | -4,661 | -6,386 | -5,834 | -7,312 |
| Net Income | $-8,714 | $-4,661 | $-6,386 | $-5,834 | $-7,312 |
| EPS Basic Total Ops | -4.35 | -2.70 | -2.55 | -4.05 | -5.10 |
| EPS Basic Continuous Ops | -4.31 | -2.64 | -2.42 | -4.05 | -5.12 |
| EPS Diluted Total Ops | -4.35 | -2.70 | -2.55 | -4.05 | -5.10 |
| EPS Diluted Continuous Ops | -4.31 | -2.64 | -2.42 | -4.05 | -5.12 |
| EBITDA(a) | $-8,853 | $-4,550 | $-6,273 | $-5,810 | $-7,275 |